 who could undergo either technique (within the criteria of the device’s instructions for use), we recommend TEVAR as the preferred approach to treat elective DTA aneurysms, given its reduced
morbidity and length of stay as well as short-term mortality. Level of recommendation: Grade 1 (Strong), Quality of Evidence: A (High).
Given the beneﬁts of TEVAR, treatment using a minimally invasive approach is largely based on anatomic eligibility
rather than on patient-spec